Organised by
Organised by
Professor
Shanghai Institute of Hypertension
Ji-Guang Wang is Professor and director at the Shanghai Institute of Hypertension and Ruijin Hospital, Shanghai Jiaotong University School of Medicine, specializing in cardiovascular medicine and hypertension.
Ji-Guang Wang is a Professor and serves as the director of the Shanghai Institute of Hypertension, as well as the director of the Department of Hypertension at Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China. His primary research interests are in cardiovascular medicine, with a particular focus on hypertension. Currently, Professor Wang coordinates several multicentre randomized clinical trials and both population- and patient-cohort studies in China. His prolific research output includes 544 full-length articles on hypertension published in the international literature and 186 articles in the Chinese literature. He has also lectured extensively at both international and national conferences in China, sharing his expertise and advancing the field of hypertension research. Professor Wang has held several prominent leadership positions in professional societies. He is a former Executive Council Member of the International Society of Hypertension, past president of the Asian-Pacific Society of Hypertension, and past president of the Pulse of Asia Society. He currently serves as deputy president of the HOPE Asia Network and president of the Chinese Hypertension League, reflecting his significant influence and leadership in the field. In addition to his research and leadership roles, Professor Wang contributes to the academic community by serving on the editorial boards of several international and national journals in the field of hypertension and cardiovascular medicine. His editorial roles include Editor-in-Chief, Associate Editor, Section Editor, and Editorial Board Member. Professor Wang's research has addressed a range of topics in hypertension and cardiovascular medicine. His recent publications include studies on the prevalence of masked hypertension in relation to cigarette smoking in Chinese males, detection rates and treatment gaps for atrial fibrillation through community health center screening, the relationship between alcohol consumption and mortality in elderly Chinese males, the impact of home blood pressure monitoring on quality of care in advanced hypertension, and the interaction between plasma advanced glycation end products, sodium dietary intake, and renal handling in relation to blood pressure. His work is characterized by a strong focus on epidemiology, clinical trials, and the improvement of hypertension management and outcomes in China. Professor Wang's contributions have had a significant impact on both the scientific community and clinical practice in cardiovascular medicine.
2024 Malaysian Society of Hypertension All Right Reserved